GlucoTrack, Inc. (GCTK) is down by 24.56 percent during Tuesday trading despite announcing the successful completion of a ...

At present, the AID is the most advanced form of insulin therapy for T1D. AID involves continuous glucose monitoring (CGM), and an algorithm is adjusted to insulin dosage based on blood glucose ...

The primary endpoint of the analysis was TIR, with the comparators grouped as subcutaneous insulin therapy without continuous glucose monitoring (SIT); subcutaneous insulin therapy with continuous ...